Toxicity of doxorubicin entrapped within long-circulating liposomes
- 1 February 1997
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 44 (1) , 1-9
- https://doi.org/10.1016/s0168-3659(96)01501-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Liposomal doxorubicin‐induced toxicity: Depletion and impairment of phagocytic activity of liver macrophagesInternational Journal of Cancer, 1995
- Efficacy of Gentamicin or Ceftazidime Entrapped in Liposomes with Prolonged Blood Circulation and Enhanced Localization in Klebsiella pneumoniae-Infected Lung TissueThe Journal of Infectious Diseases, 1995
- Antitumor Activity of Doxorubicin Encapsulated in Poly(ethylene glycol)-Coated Liposomes.Biological & Pharmaceutical Bulletin, 1995
- Enhanced tumour growth in the rat liver after selective elimination of Kupffer cellsCancer Immunology, Immunotherapy, 1993
- Fatal hepatic failure with liposomal doxorubicinThe Lancet, 1993
- Murine Kupffer cells and hepatic natural killer cells regulate tumor growth in a quantitative model of colorectal liver metastasesClinical & Experimental Metastasis, 1992
- Sterically stabilized liposomesBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1992
- Comparison of free and liposome encapsulated doxorubicin tumor drug uptake and antitumor efficacy in the SC115 murine mammary tumorCancer Letters, 1990
- Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradientsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1990
- Hepatic retention and elimination of cholesteryl linoleyl ether after injection of labeled acetylated LDL or chylomicronsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1983